We expect to advance 2-3 new therapeutic candidates into the clinic annually, and have developed the manufacturing expertise required to develop and commercialize these therapies on a broad scale.
To learn more about our team, visit the Leadership page.
To learn more about our approach, visit the Our Approach page.